what is the mechanism of action of glp 1 agonists GLP-1 Receptor as Treatments for Type 2 Diabetes Glucagon-like peptide 1 (GLP-1) -

Glutathione is essential for lymphocyte proliferation (making more immune cells when needed) and for the oxidative burst that immune cells use to kill pathogens

Several important safety considerations from UK SmPCs include: Pancreatitis risk : Seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Diabetic retinopathy complications : Particularly with semaglutide in those with pre-existing retinopathy Dehydration and acute kidney injury : Possible with severe gastrointestinal side effects Hypoglycaemia : Increased risk when used with insulin or sulfonylureas (dose adjustment of these medications may be needed) Pregnancy/breastfeeding : Weight management GLP-1 agonists (Wegovy, Saxenda) are contraindicated in pregnancy and should be avoided during breastfeeding [5] [2] Regarding mental health specifically, regulatory agencies have scrutinised GLP-1 medications for potential psychiatric adverse effects

Studied for modulation of inflammatory biomarkers under defined research conditions

G.Darley-UsmarV